3rd Quarter - Report

VENABLE LLP for GLOBAL ANTIBIOTIC RESEARCH & DEVELOPMENT PARTNERSHIP, NORTH AMERICA (GARDP NA)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 23 Labor, Health and Human Services, Education, and State and Foreign Operations appropriations regarding antibiotic research and development; FY 24 funding for antibiotic research and development.

Foreign entity interest: Global Antibiotic Research and Development Partnership (GARDP), listed on the registration, has an interest in the issues disclosed above.

LobbyistCovered position, as disclosed
JODIE CURTIS —
LAURA A HANEN —

Medical/Disease Research/Clinical Labs MED

Antibiotic research and development; S. 3799, PREVENT Pandemics Act; H.R. 3932/S. 2076, the PASTEUR Act.

Foreign entity interest: Global Antibiotic Research and Development Partnership (GARDP), listed on the registration, has an interest in the issues disclosed above.

LobbyistCovered position, as disclosed
JODIE CURTIS —
LAURA A HANEN —

Bills named: S. 3799 (117th), H.R. 3932 (117th), S. 2076 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.